Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 5, 2006, Pages 537-542

  Wilson, A M ^a   Duong, M ^b   Pratt, B ^b   Dolovich, M ^b   O'Byrne, P M ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Adenosine monophosphate; Asthma; Ciclesonide; Exhaled nitric oxide; Induced sputum

Indexed keywords

ADENOSINE PHOSPHATE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; METHACHOLINE; NITRIC OXIDE; PLACEBO;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DYSPNEA; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; TOOTH ABSCESS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; ASTHMA; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNENEDIONES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745279390     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01061.x     Document Type: Article

References (29)

1. Barnes PJ. Inhaled corticosteroids: new developments relevant to updating of asthma management guidelines. Respir Med 1996 90 : 379 384.
2. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998 94 : 557 572.
3. Stoeck M Riedel R Hochhaus G Hafner D Masso JM Schmidt B et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004 309 : 249 258.
4. Lipworth BJ Kaliner MA LaForce CF Baker JW Kaiser HB Amin D et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005 94 : 465 472.
5. Holgate ST. Adenosine provocation: a new test for allergic type airway inflammation. Am J Respir Crit Care Med 2002 165 : 317 318.
6. Wilson AM Lipworth BJ. Dose response evaluation of the therapeutic index for inhaled budesonide in mild to moderate atopic asthmatic patients. Am J Med 2000 108 : 269 275.
7. Van Den Berg M Meijer RJ Kerstjens HA de Reus DM Koeter GH Kauffman HF et al. PC20 adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001 163 : 1546 1550.
8. Taylor DA Jensen MW Kanabar V Engelstatter R Steinijans VW Barnes PJ et al. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5′-monophosphate in asthmatic patients. Am J Respir Crit Care Med 1999 160 : 237 243.
9. Postma DS Sevette C Martinat Y Schlosser N Aumann J Kafe H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 2001 17 : 1083 1088.
10. Chapman KR Patel P D'Urzo AD Alexander M Mehra S Oedekoven C et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2005 60 : 330 337.
11. Quanjer PH Tammeling GJ Cotes JE Pedersen OF Peslin R Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 16 : 5 40.
12. Juniper EF Cockcroft DW Hargreave FE. Histamine and methacholine inhalation tests: a laboratory tidal breathing protocol, 2nd edn. Lund, Sweden : Astra Draco AB, 1994.
13. Tan KS McFarlane LC Lipworth BJ. Loss of normal cyclical beta 2-adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatics. Thorax 1997 52 : 608 611.
14. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999 160 : 2104 2117.
15. Pizzichini E Pizzichini MM Efthimiadis A Evans S Morris MM Squillace D et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996 154 : 308 317.
16. Wilson AM Dempsey OJ Sims EJ Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2001 31 : 616 624.
17. Phillips K Oborne J Harrison TW Tattersfield AE. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Thorax 2004 59 : 21 25.
18. Currie GP Bates CE Lee DK Jackson CM Lipworth BJ. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients. Eur J Clin Pharmacol 2003 59 : 11 15.
19. Phillips K Oborne J Lewis S Harrison TW Tattersfield AE. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax 2004 59 : 26 30.
20. Lee DK Fardon TC Bates CE Haggart K McFarlane LC Lipworth BJ. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 2005 127 : 851 860.
21. Lee DK Haggart K Currie GP Bates CE Lipworth BJ. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma. Br J Clin Pharmacol 2004 58 : 26 33.
22. Kanniess F Richter K Bohme S Jorres RA Magnussen H. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma. Pulm Pharmacol Ther 2001 14 : 141 147.
23. Aziz I Wilson AM Lipworth BJ. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest 2000 118 : 1049 1058.
24. Snyder M Chlan L Finhelstein S Sabati N Stibbe CE. Home monitoring of pulmonary function. Home Healthc Nurse 1998 16 : 388 393.
25. Milgrom H Bender B Ackerson L Bowry P Smith B Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996 98 : 1051 1057.
26. Chowienczyk PJ Parkin DH Lawson CP Cochrane GM. Do asthmatic patients correctly record home spirometry measurements BMJ 1994 309 : 1618.
27. Simmons MS Nides MA Rand CS Wise RA Tashkin DP. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000 118 : 290 295.
28. Reddel HK Toelle BG Marks GB Ware SI Jenkins CR Woolcock AJ. Analysis of adherence to peak flow monitoring when recording of data is electronic. BMJ 2002 324 : 146 147.
29. Weinbrenner A Huneke D Zschiesche M Engel G Timmer W Steinijans VW et al. Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. J Clin Endocrinol Metab 2002 87 : 2160 2163.